Israeli Covid vaccine can defeat variants

Israel’s IIBR-developed BriLife vaccine (see here previously – now in Phase 2 testing) has advantages over vaccines such as Pfizer and Moderna. It recognizes the whole of the spike protein and can be easily adjusted to protect against mutations.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.